Literature DB >> 666459

Effect of flunarizine on calcium-induced responses of peripheral vascular smooth muscle.

J M Van Nueten, J Van Beek, P A Janssen.   

Abstract

Flunarizine, a difluoro derivative of cinnarizine, is a potent inhibitor of Ca2+-induced constriction of isolated arteries; this inhibition has a gradual onset and a prolonged duration. The present study demonstrates that flunarizine inhibits Ca2+-induced responses in the rat tail and the rabbit ear arteries, but not in isolated cat papillary muscle; flunarizine does not depress the spontaneous rhythmic activity of the rat portal-mesenteric vein. This dissociation between the arterial preparations on the one hand, was less pronounced with cinnarizine, and was not seen with verapamil and papaverine. The present experiments thus suggest that flunarizine inhibits peripheral vasoconstriction by selectively decreasing the rate of stimulated Ca2+-influx, without affecting the myogenic activity of the vascular smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 666459

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  14 in total

1.  Effects of Bay K 8644 on the spontaneous electrical and mechanical activities of the rat portal vein.

Authors:  K Shimamura; S Sunano
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-11       Impact factor: 3.000

2.  Enhanced reactivity towards flunarizine in cerebrovascular bed of spontaneously hypertensive rats.

Authors:  E Koźniewska
Journal:  Experientia       Date:  1988-03-15

3.  Cross-clamping of the thoracic aorta. Influence of aortic shunts, laminectomy, papaverine, calcium channel blocker, allopurinol, and superoxide dismutase on spinal cord blood flow and paraplegia in baboons.

Authors:  L G Svensson; C M Von Ritter; H T Groeneveld; E S Rickards; S J Hunter; M F Robinson; R A Hinder
Journal:  Ann Surg       Date:  1986-07       Impact factor: 12.969

Review 4.  Calcium antagonists. A role in the management of cyanide poisoning?

Authors:  E U Maduh; D W Porter; S I Baskin
Journal:  Drug Saf       Date:  1993-10       Impact factor: 5.606

5.  Effect of dotarizine on CO2-dependent cerebrovascular reactivity.

Authors:  J Chomicki; J Jurkiewicz; W Zabolotny; Z Czernicki; J Cervos-Navarro
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

6.  Comparison of the calcium entry and calcium overload blocking properties of R71811 and flunarizine.

Authors:  Y Matsui; I Yamagami; K Hirai
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-09       Impact factor: 3.000

7.  Local cerebral glucose utilization and local cerebral blood flow in conscious rats after administration of flunarizine.

Authors:  T Beck; J Krieglstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-06       Impact factor: 3.000

8.  Assessment of "Ca2+ -antagonist" effects of drugs in K+ -depolarized smooth muscle. Differentiation of antagonist subgroups.

Authors:  M Spedding
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

Review 9.  Flunarizine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.

Authors:  B Holmes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-01       Impact factor: 9.546

10.  Termination of a tachyarrhythmia by flunarizine is not a specific marker for a triggered mechanism.

Authors:  Sergey A Vitebskiy; Celeen M Khrestian; Albert L Waldo
Journal:  Heart Rhythm       Date:  2007-08-24       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.